Elicio Therapeutics, Inc.

The table below shows Elicio Therapeutics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.

Elicio Therapeutics, Inc. reported annual revenue of $2.30M for fiscal year 2022. That is down 91.9% from $28.31M in fiscal 2021. Figures come from the company's audited annual reports as filed with the SEC.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.